Log in to view full text. If you're not a subscriber, you can:. Colleague's E-mail is Invalid. Your message has been successfully sent to your colleague.
|Published (Last):||11 July 2019|
|PDF File Size:||19.78 Mb|
|ePub File Size:||3.92 Mb|
|Price:||Free* [*Free Regsitration Required]|
This investigation was designed to evaluate the onset time. One hundred children aged years of ASA physical status undergoing elective surgery were randomly allocated to five groups. Patients in Group E received intranasal placebo 0. Children from groups A, B, C, D and E had intravenous cannulation attempted at 30, 45, 60, 75 and 45 min respectively after intranasal drug or placebo administration.
Vital signs, behaviour and sedation status of the children were assessed regularly until induction of anaesthesia. The proportion of children who achieved satisfactory sedation was not significantly different among groups A to D.
Name your collection: Name must be less than characters. Choose a collection: Unable to load your collection due to an error Please try again.
Add Cancel. Add to My Bibliography My Bibliography. Unable to load your delegates due to an error Please try again. Your saved search Name of saved search:.
Search terms:. Test search terms. Would you like email updates of new search results? Email: change. Frequency: Monthly Weekly Daily. Which day? Send at most: 1 item 5 items 10 items 20 items 50 items items items.
Send even when there aren't any new results. Optional text in email:. Save Cancel. Create a file for external citation management software Create file Cancel. Full-text links Cite Favorites. Similar articles Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial. Sheta SA, et al. Paediatr Anaesth. Epub Nov A comparison of intranasal dexmedetomidine and oral midazolam for premedication in pediatric anesthesia: a double-blinded randomized controlled trial.
Yuen VM, et al. Anesth Analg. The safety and efficacy of intranasal dexmedetomidine during electrochemotherapy for facial vascular malformation: a double-blind, randomized clinical trial. Zhang X, et al. J Oral Maxillofac Surg. Epub Aug The sedative effects of the intranasal administration of dexmedetomidine in children undergoing surgeries compared to other sedation methods: A systematic review and meta-analysis.
Kim HJ, et al. J Clin Anesth. Epub Jan PMID: Review. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Jun JH, et al. Can J Anaesth. Epub Jun Show more similar articles See all similar articles. Cited by 24 articles Intranasal dexmedetomidine is an effective sedative agent for electroencephalography in children.
Chen H, et al. BMC Anesthesiol. Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial.
Bi Y, et al. Attenuation of haemodynamic responses to laryngoscopy and endotracheal intubation with dexmedetomidine: A comparison between intravenous and intranasal route. Niyogi S, et al. Indian J Anaesth. Epub Nov 8. Intranasal dexmedetomidine and intravenous ketamine for procedural sedation in a child with alpha-mannosidosis: a magic bullet?
Trevisan M, et al. Ital J Pediatr. Li BL, et al. J Autism Dev Disord. Show more "Cited by" articles See all "Cited by" articles. Publication types Randomized Controlled Trial Actions. Age Distribution Actions. Catheterization, Peripheral Actions.
Child Actions. Child, Preschool Actions. Drug Administration Schedule Actions. Epidemiologic Methods Actions. Female Actions. Humans Actions. Infant Actions. Male Actions. Treatment Outcome Actions. Substances Hypnotics and Sedatives Actions. Dexmedetomidine Actions. Full-text links [x] Wiley. Copy Download.
Optimal Timing for the Administration of Intranasal Dexmedetomidine for Premedication in Children
Study record managers: refer to the Data Element Definitions if submitting registration or results information. Other Name: intranasal dexmedetomidine Placebo Comparator: placebo intranasal saline Drug: placebo 0. American Society of Anesthesiologists ASA status of patients receiving intranasal placebo or dexmedetomidine. ASA V: Moribund condition in a patient who is not expected to survive with or without the operation. Anxiety score of Patients Receiving Intranasal dexmedetomidine at Pre-induction. Predicted effect-site concentrations of propofol after intranasal placebo at tracheal intubation.
Intranasal Dexmedetomidine Premedication
This study seeks to evaluate the efficacy and safety of intranasal IN dexmedetomidine as a sedative medication for non-invasive procedural sedation. Subjects 6 months to 18 years of age undergoing non-invasive elective procedures were included. IN dexmedetomidine may be used for non-invasive pediatric procedural sedation. Also, patients sedated with IN dexmedetomidine had longer time to discharge, procedure time, and total admit time in comparison to other forms of sedation.
Intranasal Dexmedetomidine as a Sedative for Pediatric Procedural Sedation
This investigation was designed to evaluate the onset time. One hundred children aged years of ASA physical status undergoing elective surgery were randomly allocated to five groups. Patients in Group E received intranasal placebo 0. Children from groups A, B, C, D and E had intravenous cannulation attempted at 30, 45, 60, 75 and 45 min respectively after intranasal drug or placebo administration. Vital signs, behaviour and sedation status of the children were assessed regularly until induction of anaesthesia.